Nephro-Urology Monthly

Published by: Kowsar

Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience

Rizna Abdul Cader 1 , * , Halim Abdul Gafor 1 , Rozita Mohd 1 , Wei Yen Kong 1 , Norazimah Arshad 1 and Norella Kong 1
Authors Information
1 Nephrology Unit, Department of Internal Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
Article information
  • Nephro-Urology Monthly: September 01, 2013, 5 (4); 891-896
  • Published Online: September 15, 2013
  • Article Type: Research Article
  • Received: May 1, 2013
  • Revised: May 28, 2013
  • Accepted: June 19, 2013
  • DOI: 10.5812/numonthly.11904

To Cite: Abdul Cader R, Abdul Gafor H, Mohd R, Yen Kong W, Arshad N, et al. Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience, Nephro-Urol Mon. 2013 ;5(4):891-896. doi: 10.5812/numonthly.11904.

Abstract
Copyright © 2013, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Cohen J. The immunopathogenesis of sepsis. Nature. 2002; 420(6917): 885-91[DOI][PubMed]
  • 2. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29(4): 530-8[DOI][PubMed]
  • 3. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989; 17(10): 975-8[PubMed]
  • 4. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol. 1995; 154(10): 5492-9[PubMed]
  • 5. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004; 30(4): 536-55[DOI][PubMed]
  • 6. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8(4)-12[DOI][PubMed]
  • 7. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med. 2002; 30(6): 1250-5[PubMed]
  • 8. Tetta C, Cavaillon JM, Schulze M, Ronco C, Ghezzi PM, Camussi G, et al. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant. 1998; 13(6): 1458-64[PubMed]
  • 9. Tetta C, Gianotti L, Cavaillon JM, Wratten ML, Fini M, Braga M, et al. Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med. 2000; 28(5): 1526-33[PubMed]
  • 10. Bellomo R, Tetta C, Brendolan A, Ronco C. Coupled plasma filtration adsorption. Blood Purif. 2002; 20(3): 289-92[PubMed]
  • 11. Cesano G, Livigni S, Vallero A, Olivieri C, Borca M, Quarello F, et al. [Treatment of septic shock with the use of CPFA (associated plasma filtration and adsorption): impact on hemodynamics monitored with PiCCO ]. G Ital Nefrol. 2003; 20(3): 258-63[PubMed]
  • 12. Formica M, Olivieri C, Livigni S, Cesano G, Vallero A, Maio M, et al. Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med. 2003; 29(5): 703-8[DOI][PubMed]
  • 13. Ronco C, Brendolan A, d'Intini V, Ricci Z, Wratten ML, Bellomo R. Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif. 2003; 21(6): 409-16[PubMed]
  • 14. Sykora R, Chvojka J, Krouzecky A, Radej J, Kuncova J, Varnerova V, et al. Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock. Shock. 2009; 31(5): 473-80[DOI][PubMed]
  • 15. Formica M, Inguaggiato P, Bainotti S, Wratten ML. Coupled plasma filtration adsorption. Contrib Nephrol. 2007; 156: 405-10[DOI][PubMed]
  • 16. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993; 21(4): 522-6[PubMed]
  • 17. Bellomo R, Ronco C. Renal replacement therapy in the intensive care unit. Crit Care Resusc. 1999; 1(1): 13-24[PubMed]
  • 18. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999; 10(4): 846-53[PubMed]
  • 19. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med. 2001; 27(6): 978-86[PubMed]
  • 20. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000; 356(9223): 26-30[DOI][PubMed]
  • 21. Hu D, Sun S, Zhu B, Mei Z, Wang L, Zhu S, et al. Effects of coupled plasma filtration adsorption on septic patients with multiple organ dysfunction syndrome. Ren Fail. 2012; 34(7): 834-9[DOI][PubMed]
  • 22. Mao HJ, Yu S, Yu XB, Zhang B, Zhang L, Xu XR, et al. Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome. Int J Artif Organs. 2009; 32(1): 31-8[PubMed]
  • 23. Lentini P, Cruz D, Nalesso F, de Cal M, Bobek I, Garzotto F, et al. [A pilot study comparing pulse high volume hemofiltration (pHVHF) and coupled plasma filtration adsorption (CPFA) in septic shock patients]. G Ital Nefrol. 2009; 26(6): 695-703[PubMed]
  • 24. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20(6): 864-74[PubMed]
  • 25. Godbole G, Gant V. Respiratory tract infections in the immunocompromised. Curr Opin Pulm Med. 2013; 19(3): 244-50[DOI][PubMed]
  • 26. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med. 2003; 168(2): 165-72[DOI][PubMed]
  • 27. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996; 275(19): 1489-94[PubMed]
  • 28. Sharifipour F, Rezaeetalab F, Naghibi M. Pulmonary fungal infections in kidney transplant recipients: an 8-year study. Transplant Proc. 2009; 41(5): 1654-6[DOI][PubMed]
  • 29. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164(3): 396-402[DOI][PubMed]
  • 30. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003; 31(6): 1737-41[DOI][PubMed]
  • 31. Prieto MF, Kilstein J, Bagilet D, Pezzotto SM. [C-reactive protein as a marker of mortality in intensive care unit]. Med Intensiva. 2008; 32(9): 424-30[PubMed]
  • 32. Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection. 2005; 33(4): 257-63[DOI][PubMed]
  • 33. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997; 50(6): 693-703[PubMed]
  • 34. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med. 1998; 26(12): 2005-9[PubMed]
  • 35. Hesselvik JF, Blomback M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med. 1989; 17(8): 724-33[PubMed]
  • 36. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med. 1983; 308(5): 258-61[DOI][PubMed]
  • 37. Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD, Jr. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis. 1999; 33(4)[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments